Stroke Prevention With Evidence-Based DOAC Therapy

Download these slides from a live webinar for expert faculty input on evidence-based recommendations on the use of DOAC therapy in NVAF for stroke prevention.
Stephanie Dwyer Kaluzna, PharmD, BCCP
Kathleen A. Lusk, PharmD, BCPS, BCCP
Format: Microsoft PowerPoint (.ppt)
File Size: 465 KB
Released: April 13, 2022

Acknowledgements

Provided by ProCE, LLC.

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Supported by educational grants from
Bristol-Myers Squibb
Pfizer Alliance

Related Content

Dr. Katherine Di Palo discusses use of novel potassium binders for the management of hyperkalemia, from ProCE

Katherine Di Palo, PharmD Released: May 13, 2022

Expert faculty provide practical strategies for successful management of hyperkalemia from ProCE

Katherine Di Palo, PharmD Michelle Richardson, PharmD, BCPS Pharmacists: 1.5 contact hours (0.15 CEUs) Released: May 12, 2022 Expired: May 11, 2023

Downloadable slides featuring expert insights on the burden of and screening methods for undiagnosed NVAF from ProCE

Stephanie Dwyer Kaluzna, PharmD, BCCP Kathleen A. Lusk, PharmD, BCPS, BCCP Released: April 13, 2022

A quick reference guide for the screening and management of NVAF, from ProCE

Stephanie Dwyer Kaluzna, PharmD, BCCP Kathleen A. Lusk, PharmD, BCPS, BCCP Released: April 13, 2022

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Cookie Settings